Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Revenue:
Revenue		$ 1,145,284	$ 1,095,090
Net investment income		282,578	257,105
Realized gains (losses)		(11,799)	(30,927)
Other income		76	50
Total revenue		1,416,139	1,321,318
Benefits and expenses:
Total policyholder benefits		731,793	707,927
Amortization of deferred acquisition costs		99,478	92,322
Commissions, premium taxes, and non-deferred acquisition costs		148,110	137,797
Other operating expense		93,214	84,171
Interest expense		28,621	24,867
Total benefits and expenses		1,101,216	1,047,084
Income before income taxes		314,923	274,234
Income tax benefit (expense)		(60,706)	(50,624)
Net income		$ 254,217	$ 223,610
Basic net income per common share (in dollars per share)		$ 2.71	$ 2.32
Diluted net income per common share (in dollars per share)		$ 2.67	$ 2.28
Life premium
Revenue:
Revenue		$ 804,265	$ 772,597
Benefits and expenses:
Total policyholder benefits	[1]	519,871	507,977
Health premium
Revenue:
Revenue		341,019	322,493
Benefits and expenses:
Total policyholder benefits	[2]	202,327	190,962
Other premium
Revenue:
Revenue		0	0
Benefits and expenses:
Total policyholder benefits		$ 9,595	$ 8,988

[1] Net of a remeasurement gain of $4.9 million for the three months ended March 31, 2024, and a remeasurement gain of $2.7 million for the same period in 2023.

[2] Net of a remeasurement gain of $3.2 million for the three months ended March 31, 2024, and a remeasurement loss of $2.0 million for the same period in 2023.